Search the Newsreel

MediaAlpha (NYSE: MAX) CRO stock sale follows RSU vesting

MediaAlpha's Chief Revenue Officer, Keith Cramer, reported the sale of 13,000 Class A shares for approximately $166,000, executed under a Rule 10b5-1 trading plan primarily to cover tax obligations from vested Restricted Stock Units (RSUs). These RSUs, granted in 2023 and 2024, resulted in …

MediaAlpha (NYSE: MAX) CFO covers taxes with 24K shares

MediaAlpha's CFO, Thompson Patrick Ryan, reported four Form 4 transactions on August 15, 2026, involving the disposal of 24,209 shares of Class A Common Stock. These transactions, valued at $13.17 per share, were code F dispositions, indicating shares withheld automatically to cover tax obligations …

MediaAlpha (MAX) withholds 14K GC shares for vesting RSU taxes

MediaAlpha, Inc. (MAX) General Counsel and Secretary, Jeffrey B. Coyne, reported four code F transactions on August 15, 2026, where 14,182 shares of Class A Common Stock were withheld at $13.17 per share. This withholding was to cover tax obligations related to the vesting …

DiaMedica (DMAC) Q2 2026 Earnings Call Transcript

Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) after the FDA issued a Complete Response Letter for its bitopertin program, causing a 22% stock drop. The firm encourages investors who purchased Disc Medicine securities to inquire about …

Mobia Medical Director Purchased Shares Worth Over $797K

Tansey Casey M, a Director at Mobia Medical, purchased shares worth over $797,000 across multiple transactions on August 13, 14, and 17, 2026. The purchases involved weighted average prices ranging from $11.5073 to $12.53. Following these transactions, Tansey Casey M directly holds 301,891 shares …

Shilpa Medicare details TDS rules for Re. 0.60 dividend payout

Medical Properties Trust (MPT) Q2 2026 Earnings Call Transcript

Medical Properties Trust (MPT) reported a comprehensive $2.4 billion refinancing strategy for Q2 2026, eliminating debt maturities through 2027 and extending the runway to June 2028. The company emphasized its strategic asset sales and the successful IPO of its Swiss joint venture, InfraCore, as …

China Medical System's Profit Rises in H1 as Turnover Jumps 12.5%

Smart Money is Buying Versant Media Group Inc. (VSNT)

Institutional investors, including prominent hedge funds and value investors, have shown significant buying interest in Versant Media Group Inc. (VSNT), with several initiating new positions during the last quarter. This buying activity highlights broad early institutional interest across various investment strategies. The largest new …

Medicenna Therapeutics Corp (MDNAF) Q3 2026 Earnings Report - Results, Call & Slides

What's Going On With Blue Ant Media Corporation Stock Monday?

Why Jinhai Medical Technology (SEHK:2225) Shares Climbed On Its Latest Update

TransMedics (TMDX) director gifts 18,000 shares

TransMedics Group, Inc. director James R. Tobin reported a bona fide gift transfer of 18,000 shares of common stock from "The Tobin 2024 Family Trust" on August 17, 2026. Following this transaction, the trust holds 0 shares, while Tobin directly holds 6,981 shares and …

ENvue Medical, Inc. 2026: Revenue $239K, EPS ($1.98) — 10-Q Summary

ENvue Medical (FEED) raises going-concern doubt, adds equity facility

Top Medical Properties Trust (MPT) Competitors 2026

Kestra Medical (NASDAQ: KMTS) holder plans new sale after $1.27M August trade

Brian Webster, a holder of Kestra Medical Technologies (KMTS) stock, has filed a Form 144 to sell 15,000 shares valued at approximately $412,180.90 on August 17, 2026. These shares were granted as part of an equity compensation plan on July 14, 2026. The filing …

Trump Media Slides 4% as It Abandons Its Bitcoin Treasury Bet, Rumble Gains 4%

Quick Read Trump Media abandoned its bitcoin treasury after a $190 million paper loss, with Rumble gaining 4% as investors rotated to crypto-free alt-media. MSTR sits on a $10 billion bitcoin paper loss and faces forced-selling risk as the corporate crypto treasury model loses …

PROF Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Shares Slide 0.75% - Earnings Sentiment Score

IceCure Medical (ICCM) grants 131K RSUs to North America VP

IceCure Medical (ICCM) has granted 131,483 restricted share units (RSUs) to Good Shad, its VP of Sales for North America, on August 14, 2026. These RSUs will vest 25% on August 11, 2027, with the remainder vesting in twelve equal quarterly installments. Following this …

NCMI Q1 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 4.37% - Post-Earnings Drift

Profound Medical (TSE:PRN) Insider Thomas Michael Tamberrino Buys 3,755 Shares of Stock

Profound Medical insider Thomas Michael Tamberrino recently purchased 3,755 shares of the company's stock for C$9.44 per share, increasing his total ownership by 7.54% to 53,573 shares. This insider buying comes as the company reported weak financial results, including a quarterly loss of C$0.37 …

Price to earnings forward of Twareat Medical Care Co. – TADAWUL:9627

Transcript : Medios AG, H1 2026 Earnings Call, Aug 12, 2026

Why Revolution Medicines (RVMD) Stock Is Up Today

Revolution Medicines (RVMD) stock rose 5.5% today, primarily driven by continued investor optimism after the U.S. FDA accepted its new drug application for daraxonrasib, a treatment for previously treated metastatic pancreatic cancer. The positive movement is further supported by recent bullish analyst commentary and …

NCMI Slips 4.37% to $2.73 as National CineMedia Tests Key Support Zone - Aggressive Growth Picks

NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Call Highlights: Revenue Grows 16% But Supply Chain Constraints Force Guidance Cut

NeuroOne Medical Technologies Corp (NMTC) reported a 16% increase in Q3 fiscal 2026 product revenue and strong order growth, with significant gross margin expansion. Despite positive developments like ISO 13485 certification and progress in drug delivery platforms, the company faced significant manufacturing and supply …

Why Medipharm Labs Corp stock is skyrocketing today

NMTC Q2 2026 Earnings: EPS Miss Widens Net Loss to -$0.28 Despite 1.86% Share Gain - Cost Structure Review

Here is Why Growth Investors Should Buy Globus Medical (GMED) Now

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. By their very …

Is Outfront Media (OUT) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. That's because, these …

Revolution Medicines stock hits all-time high at 208.77 USD

Revolution Medicines Inc. (RVMD) stock reached an all-time high of $208.77, currently trading at $208.48, reflecting a remarkable 468.97% increase over the past year. Despite being considered overvalued by InvestingPro analysis, the company closed Q2 with $3.9 billion in cash and investments and is …

Baosheng Media to acquire 40% stake in Blue Intelligence Cloud Innovation Technology

Baosheng Media has entered into a non-binding memorandum to acquire a 40% equity interest in Blue Intelligence Cloud Innovation Technology. The acquisition aims to expand Baosheng's reach into AI marketing, including AI-driven traffic acquisition, user analytics, content generation, and marketing conversion. Blue Intelligence Cloud …

Core Thesis on Lifecore Biomedical (LFCR): Monetizing Excess Production

Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the …

Praxis Precision Medicines stock hits 52-week high at 388.27 USD

Praxis Precision Medicines (PRAX) stock has reached a new 52-week high of $388.27, marking a 721.64% increase over the past year with a market capitalization of $10.77 billion. Despite being unprofitable, this surge reflects investor confidence and recent positive developments, including a narrower-than-expected Q2 …